|
|
|
|
||
Re: Sangamo and Shire Restructure Collaboration to Accelerate Development of ZFP Therapeutics(R) for the Treatment of Hemophilia and Huntington's DiseaseShire walking away could never be a good thing....now SGMO has an increased cost burden....... |
return to message board, top of board |